| # | Title | Journal | Year | Citations |
|---|
| 1 | The platelet release reaction: granules' constituents, secretion and functions | Platelets | 2001 | 471 |
| 2 | Mean platelet volume as an indicator of platelet activation: methodological issues | Platelets | 2002 | 421 |
| 3 | Mean platelet volume in patients with type 2 diabetes mellitus | Platelets | 2004 | 295 |
| 4 | Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel | Platelets | 2001 | 247 |
| 5 | Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study | Platelets | 2020 | 234 |
| 6 | The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane | Platelets | 2018 | 233 |
| 7 | Platelets in wound healing and regenerative medicine | Platelets | 2018 | 218 |
| 8 | Platelets in inflammation and infection | Platelets | 2015 | 217 |
| 9 | The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity | Platelets | 2010 | 204 |
| 10 | The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events | Platelets | 2015 | 200 |
| 11 | An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume | Platelets | 2009 | 178 |
| 12 | The role of platelet-rich plasma in tissue regeneration | Platelets | 2013 | 175 |
| 13 | Generation of reactive oxygen species in blood platelets | Platelets | 2002 | 174 |
| 14 | Platelet microvesicles in health and disease | Platelets | 2017 | 174 |
| 15 | Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity andin vivobone formation in calcium phosphate ceramics | Platelets | 2006 | 171 |
| 16 | New roles for mean platelet volume measurement in the clinical practice? | Platelets | 2016 | 164 |
| 17 | Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells underin vitroconditions | Platelets | 2004 | 163 |
| 18 | Resveratrol, a phenolic antioxidant with effects on blood platelet functions | Platelets | 2005 | 157 |
| 19 | Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma | Platelets | 2018 | 157 |
| 20 | Flow cytometric measurement of microparticles: Pitfalls and protocol modifications | Platelets | 2008 | 152 |
| 21 | Variables influencing Multiplate™ whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals | Platelets | 2007 | 147 |
| 22 | The role of platelets in the recruitment of leukocytes during vascular disease | Platelets | 2015 | 146 |
| 23 | Towards a definition of aspirin resistance: a typological approach | Platelets | 2002 | 144 |
| 24 | Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease | Platelets | 2002 | 140 |
| 25 | Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study | Platelets | 2014 | 138 |
| 26 | The presence and release of tissue factor from human platelets | Platelets | 2002 | 136 |
| 27 | Extracellular vesicles from activated platelets: a semiquantitative cryo-electron microscopy and immuno-gold labeling study | Platelets | 2017 | 134 |
| 28 | First report of the point-of-care TEG: A technical validation study of the TEG-6S system | Platelets | 2016 | 133 |
| 29 | Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms | Platelets | 2009 | 129 |
| 30 | Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses | Platelets | 2008 | 128 |
| 31 | Measurement of whole blood thrombus formation using parallel-plate flow chambers – a practical guide | Platelets | 2012 | 127 |
| 32 | Cytokine, chemokine, and growth factor profile of platelet-rich plasma | Platelets | 2016 | 126 |
| 33 | The Basic Pharmacology of Ticlopidine and Clopidogrel | Platelets | 1993 | 125 |
| 34 | Altered megakaryocyte–platelet haemostatic axis in hypercholesterolaemia | Platelets | 2001 | 125 |
| 35 | Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count | Platelets | 2020 | 124 |
| 36 | Platelet-rich plasma (PRP): Methodological aspects and clinical applications | Platelets | 2015 | 118 |
| 37 | Clopidogrel: a review of its mechanism of action | Platelets | 1998 | 113 |
| 38 | The P2Y 12 receptor as a therapeutic target in cardiovascular disease | Platelets | 2001 | 112 |
| 39 | Measuring and interpreting platelet-leukocyte aggregates | Platelets | 2018 | 112 |
| 40 | Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers | Platelets | 2004 | 110 |
| 41 | Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy | Platelets | 2000 | 109 |
| 42 | Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time | Platelets | 2003 | 109 |
| 43 | Neonatal platelets from cord blood and peripheral blood | Platelets | 2005 | 108 |
| 44 | ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets | Platelets | 1996 | 107 |
| 45 | Can platelet aggregometry be standardized? | Platelets | 2005 | 107 |
| 46 | The mean platelet volume in subjects with impaired fasting glucose | Platelets | 2006 | 107 |
| 47 | Quantification of growth factors in different platelet concentrates | Platelets | 2017 | 107 |
| 48 | Effects of P2Y 1 and P2Y 12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood | Platelets | 2001 | 106 |
| 49 | The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence | Platelets | 2008 | 106 |
| 50 | Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids | Platelets | 2017 | 106 |
